Clinical trial
Clinical Evaluation of the BD NEXT (Extra Thin Wall Pen Needles) Compared to the Currently Marketed Pen Needles
NCT01852136 is registered in ClinicalTrials.gov with Becton, Dickinson and Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Evaluation of the BD NEXT (Extra Thin Wall Pen Needles) Compared to the Currently Marketed Pen Needles
- Lead sponsor
- Becton, Dickinson and Company
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 30, 2012
- Completion date
- December 31, 2012
- Enrollment
- 217 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.